Skip to content
SIME Clinical AISIME Clinical AI
  • ABOUT
  • PRODUCT
    • Neonatal Intensive Care
    • Adult Intensive Care
  • DATA
  • NEWS
  • Insights
  • CONTACT
BROWSE ARTICLES
  • AI
  • Award
  • COVID-19
  • Insights
  • Machine learning
  • Media
  • Medium
  • Neonatal Lung Maturity Test
  • News
  • Patent
  • Press release
Investing in our future starts with prioritising infant healthcare

A recent study published in The Lancet suggests that falling fertility rates across nearly every [...]

02
Sep
AI Predicts Newborn Chronic Lung Disease in Breakthrough Clinical Study

Innovative screening test has the potential to enable early preventative care for millions of babies [...]

08
Jul
SIME Announces Exclusive Agreement for Commercialisation of Respiratory Diagnostic Platform in Latin America

Partnership will accelerate path to commercialisation of novel respiratory diagnostics LONDON, May 7, 2020 /PRNewswire/ — Today, [...]

07
May
Press Release: ‘SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care’

Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company [...]

06
May
HOW CLINICAL AI IS GENERATING UNIQUE DATA FROM YOUR BIOLOGY

Published online on Medium, 17th April 2019 Over a decade ago, the human genome was [...]

17
Apr
WORLD PREMATURITY DAY INFOGRAPHIC

World Prematurity Day is observed on 17 November each year to raise awareness of preterm [...]

17
Nov
PRESS RELEASE: SIME AWARDED PATENT FOR NEONATAL POINT-OF-CARE LUNG MATURITY TEST (LMT)

SIME Dx today announced that the European Patent Office intends to grant patent number 14727196.9 [...]

09
Oct
MICROSOFT FEATURE: HOW MACHINE LEARNING WILL TRANSFORM CARE FOR MILLIONS OF PREMATURE BABIES IN CHINA

At SIME Diagnostics we are developing a digital platform that can measure multiple biomarkers, from [...]

04
Oct
PRESS RELEASE: SIME DX ANNOUNCES NEW DESIGN FOR LUNG MATURITY DIAGNOSTIC DEVICE

LONDON, August 15, 2018 /PRNewswire/ — Device fully automates neonatal Lung Maturity Test (LMT),representing a major milestone achievement andputtingLMT on track for final clinical validation and [...]

15
Aug
AWARD: SIME DX SELECTED BY DISRUPT 100 AS ONE OF 100 GLOBAL BUSINESSES ‘WITH THE MOST POTENTIAL TO INFLUENCE, CHANGE, OR CREATE NEW GLOBAL MARKETS.’

The report tracks the world’s most disruptive businesses, compiled and curated by the world’s leading [...]

06
Jul
  • 1
  • 2
  • 3
Copyright 2023 © SIME DIAGNOSTICS LTD

43 MANCHESTER STREET, LONDON, ENGLAND, W1U 7LP

  • ABOUT
  • PRODUCT
    • Neonatal Intensive Care
    • Adult Intensive Care
  • DATA
  • NEWS
  • Insights
  • CONTACT